លោក អ៊ូល ហ្សាហ៊ីន អ្នកវិទ្យាសាស្រ្តរកឃើញវ៉ាក់សាំងកូវីដ-១៩
Category
🗞
NewsTranscript
00:00You have played an important role in saving lives around the world by preventing the spread of COVID-19.
00:10Mr. Ul Shahin, a scientist who prevented the spread of COVID-19
00:15Mr. Ul Shahin, a scientist from Germany, is a member of the BioNTech research team.
00:31The BioNTech team has been working with the American company Pfizer to develop the Pfizer BioNTech vaccine, which has a 95% chance of preventing COVID-19.
00:44The development of this vaccine has greatly increased the cost of the world's economy.
00:49In this new era, the world and the United States must have a representative of the German government,
00:54Minister of Foreign Affairs, and Commander-in-Chief for the participation of both parties
01:00in preventing the spread of this deadly virus that has taken the lives of more than 2.5 billion people
01:06and killed more than 122 billion people worldwide.
01:09What is the history of Mr. Ul Shahin? Please watch the following video.
01:16Family and health
01:19Mr. Ul Shahin was born on September 29, 1965, in Iskanderun, Turkey.
01:27He has been working in Germany since the age of 4 to live with his mother, who is working in a fort.
01:35After graduating, Mr. Ul Shahin is a child who likes science very much.
01:40He graduated from the Catholic University of Germany.
01:45Mr. Ul Shahin graduated from the Erich Kastner Gymnasium in Cologne,
01:52with a master's degree in science and chemistry.
01:56In 1985, he studied economics at the University of Cologne and graduated in 1992.
02:06From 1992 to 1995, he studied law at the University of Hagen.
02:16Career
02:18Mr. Ul Shahin graduated from the Faculty of Law in Cologne from 1991 to 2000
02:29and graduated from the Faculty of Law in Saarland in Hamburg.
02:33In 2000, he went to work at the Messe.
02:37Since then, Mr. Ul Shahin has been involved in a number of important projects
02:42such as the research on the molecule of molybdenum and chlorine since 2001
02:47and was awarded the title of Associate Professor of Molecular Biology at the University of Saarland in 2006.
02:54Mr. Ul Shahin has been involved in the development of new molecules for the development of molybdenum
03:00such as molybdenum-sodium, molybdenum-prostate, molybdenum-sodium, and molybdenum-sodium.
03:07The goal of the research is to create a molybdenum-forming molecule.
03:11Development of new molecules
03:14In 2001, Mr. Ul Shahin and his colleagues developed a new molecule called Ganymede Pharmaceuticals.
03:21This new molecule is a type of preservative that has to be used to be used with molybdenum.
03:29In 2016, this new molecule was sold to Astella Pharma for $100 million.
03:37This new molecule is a new molecule that has to be used with molybdenum.
03:43This new molecule is a new molecule that has to be used with molybdenum.
03:51COVID-19
03:54Mr. Ul Shahin is a member of the BioNTech Research Group
03:59which was established in 2008 and has a headquarters in Manzer, Germany.
04:03Mr. Ul Shahin is a member of the BioNTech Research Group
04:08which was established in 2008 and has a headquarters in Manzer, Germany.
04:14Since then, BioNTech has focused on the development of a new molybdenum-forming molecule
04:21that has to be used with molybdenum.
04:25Since then, BioNTech has focused on the development of a new molybdenum-forming molecule
04:33that has to be used with molybdenum.
04:39In 2020, the U.S. government signed an agreement with Pfizer to develop a new molybdenum-forming molecule.
04:48In 2020, the U.S. government signed an agreement with Pfizer to develop a new molybdenum-forming molecule.
04:58Life is full of surprises.
05:01Mr. Ul Shahin met his future wife, Ms. Ursula Teresi,
05:05when he was working at the Scholarship School in Hamburg,
05:10where his future wife went to study.
05:13The two scientists have been working together since 2002
05:18and they have a daughter together.
05:21Mr. Ul Shahin and Ms. Ursula Teresi are in a long-term relationship in Germany.
05:25In the middle of 2021, Forbes magazine reported that
05:31they have a total of $4.6 trillion.